BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

532 related articles for article (PubMed ID: 3525085)

  • 1. Current issues in thrombosis prevention with antiplatelet drugs.
    de Gaetano G; Cerletti C; Dejana E; Vermylen J
    Drugs; 1986 Jun; 31(6):517-49. PubMed ID: 3525085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An overview of antiplatelet and antithrombotic drugs.
    Verstraete M; Dejana E; Fuster V; Lapetina E; Moncada S; Mustard JF; Tans G; Vargaftig BB
    Haemostasis; 1985; 15(2):89-99. PubMed ID: 3159632
    [No Abstract]   [Full Text] [Related]  

  • 3. Aspirin and platelets: the antiplatelet action of aspirin and its role in thrombosis treatment and prophylaxis.
    Schrör K
    Semin Thromb Hemost; 1997; 23(4):349-56. PubMed ID: 9263351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Action mechanism and clinical indications for thrombocyte aggregation inhibitors].
    Oelz O
    Schweiz Med Wochenschr; 1979 Mar; 109(10):348-53. PubMed ID: 424707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysing responses to aspirin and clopidogrel by measuring platelet thrombus formation under arterial flow conditions.
    Hosokawa K; Ohnishi T; Sameshima H; Miura N; Ito T; Koide T; Maruyama I
    Thromb Haemost; 2013 Jan; 109(1):102-11. PubMed ID: 23179055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostaglandins, platelets, and atherosclerosis.
    Gryglewski RJ
    CRC Crit Rev Biochem; 1980; 7(4):291-338. PubMed ID: 6771102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel antithrombotic drugs in development.
    Verstraete M; Zoldhelyi P
    Drugs; 1995 Jun; 49(6):856-84. PubMed ID: 7641602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiplatelet drugs.
    De Meyer SF; Vanhoorelbeke K; Broos K; Salles II; Deckmyn H
    Br J Haematol; 2008 Aug; 142(4):515-28. PubMed ID: 18513285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiplatelet drugs--do we need new options? With a reappraisal of direct thromboxane inhibitors.
    Coccheri S
    Drugs; 2010 May; 70(7):887-908. PubMed ID: 20426498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspirin as an antithrombotic drug: from the aggregometer to clinical trials.
    de Gaetano G
    Verh K Acad Geneeskd Belg; 1990; 52(6):459-71; discussion 471-3. PubMed ID: 2150736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aspirin and other platelet-aggregation inhibiting drugs.
    Gallus AS
    Med J Aust; 1985 Jan; 142(1):41-7. PubMed ID: 3880861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Thrombosis and coronary disease: neutrophils, nitric oxide and aspirin].
    López-Farré A; Farré J; Sánchez de Miguel L; Romero J; Gómez J; Rico L; Casado S
    Rev Esp Cardiol; 1998 Mar; 51(3):171-7. PubMed ID: 9577162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced Antiplatelet Effect of Aspirin Does Not Predict Cardiovascular Events in Patients With Stable Coronary Artery Disease.
    Larsen SB; Grove EL; Neergaard-Petersen S; Würtz M; Hvas AM; Kristensen SD
    J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28780510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiplatelet drugs: clinical pharmacology and therapeutic use.
    Gallus AS
    Drugs; 1979 Dec; 18(6):439-77. PubMed ID: 391530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apigenin inhibits platelet adhesion and thrombus formation and synergizes with aspirin in the suppression of the arachidonic acid pathway.
    Navarro-Núñez L; Lozano ML; Palomo M; Martínez C; Vicente V; Castillo J; Benavente-García O; Diaz-Ricart M; Escolar G; Rivera J
    J Agric Food Chem; 2008 May; 56(9):2970-6. PubMed ID: 18410117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are agents affecting platelet functions clinically useful?
    Verstraete M
    Am J Med; 1976 Dec; 61(6):897-914. PubMed ID: 795299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of platelets and thrombosis in mechanisms of acute occlusion and restenosis after angioplasty.
    Harker LA
    Am J Cardiol; 1987 Jul; 60(3):20B-28B. PubMed ID: 2956836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostaglandin endoperoxides and thromboxane A2 in thrombus formation in the hamster cheek pouch in vivo.
    Lewis GP; Smith JR
    Prostaglandins; 1984 Jul; 28(1):29-41. PubMed ID: 6435186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antithrombotic effects of drugs which suppress platelet function: their potential in prevention growth of tumour cells.
    Turpie AG
    Prog Clin Biol Res; 1982; 89():31-62. PubMed ID: 7051035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 10. Antithrombotic therapy: role of platelet-inhibitor drugs. II. Pharmacologic effects of platelet-inhibitor drugs (second of three parts).
    Fuster V; Chesebro JH
    Mayo Clin Proc; 1981 Mar; 56(3):185-95. PubMed ID: 7010003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.